| Financial Year |
March 31 2023 |
| Monetary Funds |
223,644,320,158.91 |
| Held-for-trading Financial Assets |
100,255,229.46 |
| Notes Receivable |
274,964,025.24 |
| Accounts Receivable |
8,387,593,818.93 |
| Advances to Suppliers |
2,038,689,768.79 |
| Other Receivables |
3,059,276,845.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,558,313,145.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
107,543,976.46 |
| Other Current Assets |
2,133,243,884.11 |
| Total Current Assets |
246,562,027,557.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
669,143,162.73 |
| Long-term Equity Investment |
64,187,977,285.58 |
| Investment Properties |
3,971,376,249.78 |
| Fixed Assetes |
102,713,944,049.86 |
| Under-construction Projects |
17,598,536,779.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,573,351,544.97 |
| R&D expenses |
-- |
| Goodwill |
6,042,743,045.69 |
| Long-Term Deferred and Prepaid Expenses |
361,216,032.03 |
| Deferred Income Tax Assets |
1,038,928,075.22 |
| Other Non-Current Assets |
388,186,493.80 |
| Sub-Total of Non-Current Assets |
254,393,296,846.96 |
| Total Assets |
500,955,324,404.93 |
| Short-Term Loans |
2,394,840,897.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,000,000.00 |
| Accounts Payable |
104,765,887,722.16 |
| Accounts Received In Advance |
36,889,826.81 |
| Employee Compensation Payable |
9,377,845,095.40 |
| Taxes Payable |
2,480,870,832.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,637,059,093.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,428,429,405.17 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
144,032,858,165.15 |
| Long-term Loans |
34,405,319,072.28 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
465,948,362.62 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,301,572,593.70 |
| Deferred Income Tax Liabilities |
17,423,097,962.42 |
| Other Non-Current Liabilities |
1,655,502,656.50 |
| Sub-Total of Non-Current Liabilities |
96,884,121,208.43 |
| Total Liabilities |
240,916,979,373.58 |
| Paid-In Capital(Or Share Stock) |
16,095,391,286.00 |
| Capital Surplus |
30,703,993,873.41 |
| Surplus Reserve |
10,573,005,688.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
149,770,411,275.85 |
| Minority Stockholder's Interest |
53,416,881,646.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
206,621,463,384.60 |
| Owner's Equity（Stockholder's Equity） |
260,038,345,031.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
500,955,324,404.93 |
